ALMEX Fundamental Analysis - MEXEDIA SPA

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to ALMEX. ALMEX was compared to 30 industry peers in the Diversified Telecommunication Services industry. ALMEX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALMEX does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALMEX has reported negative net income.

In the past year ALMEX had a positive cash flow from operations.

ALMEX had positive earnings in 4 of the past 5 years.

In multiple years ALMEX reported negative operating cash flow during the last 5 years.

1.2 Ratios

With a Return On Assets value of -12.70%, ALMEX is not doing good in the industry: 83.33% of the companies in the same industry are doing better.

Looking at the Return On Equity, with a value of -42.25%, ALMEX is doing worse than 86.67% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-12.7%
ROE	-42.25%
ROIC	N/A

ROA(3y)-1.83%

ROA(5y)2.5%

ROE(3y)-9.5%

ROE(5y)5.81%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALMEX has a Gross Margin of 10.15%. This is amonst the worse of the industry: ALMEX underperforms 86.67% of its industry peers.

ALMEX's Gross Margin has improved in the last couple of years.

ALMEX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	10.15%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y9.41%

GM growth 5Y36.9%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALMEX does not have a ROIC to compare to the WACC, probably because it is not profitable.

ALMEX has about the same amout of shares outstanding than it did 1 year ago.

The number of shares outstanding for ALMEX remains at a similar level compared to 5 years ago.

ALMEX has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.77, we must say that ALMEX is in the distress zone and has some risk of bankruptcy.

ALMEX has a worse Altman-Z score (0.77) than 83.33% of its industry peers.

ALMEX has a debt to FCF ratio of 3.19. This is a good value and a sign of high solvency as ALMEX would need 3.19 years to pay back of all of its debts.

The Debt to FCF ratio of ALMEX (3.19) is better than 93.33% of its industry peers.

ALMEX has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.

The Debt to Equity ratio of ALMEX (0.10) is better than 100.00% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.1
Debt/FCF	3.19
Altman-Z	0.77

ROIC/WACCN/A

WACC7.58%

2.3 Liquidity

A Current Ratio of 1.12 indicates that ALMEX should not have too much problems paying its short term obligations.

The Current ratio of ALMEX (1.12) is better than 83.33% of its industry peers.

A Quick Ratio of 1.12 indicates that ALMEX should not have too much problems paying its short term obligations.

The Quick ratio of ALMEX (1.12) is better than 90.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.12
Quick Ratio	1.12

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for ALMEX have decreased strongly by -547.54% in the last year.

The Revenue for ALMEX has decreased by -77.49% in the past year. This is quite bad

ALMEX shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -13.26% yearly.

EPS 1Y (TTM)-547.54%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

Revenue 1Y (TTM)-77.49%

Revenue growth 3Y-17.91%

Revenue growth 5Y-13.26%

Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y88.15%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year7.33%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALMEX. In the last year negative earnings were reported.

Based on the Price/Forward Earnings ratio of 10.55, the valuation of ALMEX can be described as reasonable.

ALMEX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ALMEX is cheaper than 73.33% of the companies in the same industry.

ALMEX is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.23, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	10.55

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ALMEX is valued expensively inside the industry as 80.00% of the companies are valued cheaper.

		Industry Rank	Sector Rank
P/FCF	100.27
EV/EBITDA	N/A

4.3 Compensation for Growth

ALMEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALMEX!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MEXEDIA SPA

EPA:ALMEX (10/21/2025, 7:00:00 PM)

27.6

+1.2 (+4.55%)

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupTelecommunication Services

GICS IndustryDiversified Telecommunication Services

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners0.09%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap157.32M

Revenue(TTM)72.90M

Net Income(TTM)-20010000

Analysts86

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	10.55
P/S	2.16
P/FCF	100.27
P/OCF	19.05
P/B	3.32
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-3.51

EYN/A

EPS(NY)2.62

Fwd EY9.48%

FCF(TTM)0.28

FCFY1%

OCF(TTM)1.45

OCFY5.25%

SpS12.79

BVpS8.31

TBVpS-4.56

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-12.7%
ROE	-42.25%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	10.15%
FCFM	2.15%

ROA(3y)-1.83%

ROA(5y)2.5%

ROE(3y)-9.5%

ROE(5y)5.81%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y9.41%

GM growth 5Y36.9%

F-Score4

Asset Turnover0.46

Health

		Industry Rank	Sector Rank
Debt/Equity	0.1
Debt/FCF	3.19
Debt/EBITDA	N/A
Cap/Depr	520.54%
Cap/Sales	9.18%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.12
Quick Ratio	1.12
Altman-Z	0.77

F-Score4

WACC7.58%

ROIC/WACCN/A

Cap/Depr(3y)961.45%

Cap/Depr(5y)N/A

Cap/Sales(3y)4.19%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-547.54%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

EPS Next Y88.15%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-77.49%

Revenue growth 3Y-17.91%

Revenue growth 5Y-13.26%

Sales Q2Q%N/A

Revenue Next Year7.33%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-293.2%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year45.8%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y114.78%

FCF growth 3YN/A

FCF growth 5Y-13.29%

OCF growth 1Y16092.2%

OCF growth 3YN/A

OCF growth 5Y20.87%

MEXEDIA SPA (ALMEX.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens